1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Targeted Drug ALK Inhibitors for NSCLC Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Crizotinib 1.2.3 Ceritinib 1.2.4 Alectinib 1.2.5 Brigatinib 1.2.6 Lorlatinib 1.2.7 Other 1.3 Market by Application 1.3.1 Global Targeted Drug ALK Inhibitors for NSCLC Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Squamous Cell Carcinoma of NSCLC 1.3.3 Adenocarcinoma of NSCLC 1.3.4 Large Cell Carcinoma of NSCLC 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Targeted Drug ALK Inhibitors for NSCLC Market Perspective (2016-2027) 2.2 Targeted Drug ALK Inhibitors for NSCLC Growth Trends by Regions 2.2.1 Targeted Drug ALK Inhibitors for NSCLC Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Targeted Drug ALK Inhibitors for NSCLC Historic Market Share by Regions (2016-2021) 2.2.3 Targeted Drug ALK Inhibitors for NSCLC Forecasted Market Size by Regions (2022-2027) 2.3 Targeted Drug ALK Inhibitors for NSCLC Industry Dynamic 2.3.1 Targeted Drug ALK Inhibitors for NSCLC Market Trends 2.3.2 Targeted Drug ALK Inhibitors for NSCLC Market Drivers 2.3.3 Targeted Drug ALK Inhibitors for NSCLC Market Challenges 2.3.4 Targeted Drug ALK Inhibitors for NSCLC Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Targeted Drug ALK Inhibitors for NSCLC Players by Revenue 3.1.1 Global Top Targeted Drug ALK Inhibitors for NSCLC Players by Revenue (2016-2021) 3.1.2 Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Players (2016-2021) 3.2 Global Targeted Drug ALK Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Targeted Drug ALK Inhibitors for NSCLC Revenue 3.4 Global Targeted Drug ALK Inhibitors for NSCLC Market Concentration Ratio 3.4.1 Global Targeted Drug ALK Inhibitors for NSCLC Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Targeted Drug ALK Inhibitors for NSCLC Revenue in 2020 3.5 Targeted Drug ALK Inhibitors for NSCLC Key Players Head office and Area Served 3.6 Key Players Targeted Drug ALK Inhibitors for NSCLC Product Solution and Service 3.7 Date of Enter into Targeted Drug ALK Inhibitors for NSCLC Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Targeted Drug ALK Inhibitors for NSCLC Breakdown Data by Type 4.1 Global Targeted Drug ALK Inhibitors for NSCLC Historic Market Size by Type (2016-2021) 4.2 Global Targeted Drug ALK Inhibitors for NSCLC Forecasted Market Size by Type (2022-2027) 5 Targeted Drug ALK Inhibitors for NSCLC Breakdown Data by Application 5.1 Global Targeted Drug ALK Inhibitors for NSCLC Historic Market Size by Application (2016-2021) 5.2 Global Targeted Drug ALK Inhibitors for NSCLC Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Targeted Drug ALK Inhibitors for NSCLC Market Size (2016-2027) 6.2 North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Type 6.2.1 North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2021) 6.2.2 North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2022-2027) 6.2.3 North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2027) 6.3 North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Application 6.3.1 North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2021) 6.3.2 North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2022-2027) 6.3.3 North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2027) 6.4 North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Country 6.4.1 North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2016-2021) 6.4.2 North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size (2016-2027) 7.2 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Type 7.2.1 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2021) 7.2.2 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2022-2027) 7.2.3 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2027) 7.3 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Application 7.3.1 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2021) 7.3.2 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2022-2027) 7.3.3 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2027) 7.4 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Country 7.4.1 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2016-2021) 7.4.2 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size (2016-2027) 8.2 Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Type 8.2.1 Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2027) 8.3 Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Application 8.3.1 Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2027) 8.4 Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Region 8.4.1 Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size (2016-2027) 9.2 Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Type 9.2.1 Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2021) 9.2.2 Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2022-2027) 9.2.3 Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2027) 9.3 Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Application 9.3.1 Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2021) 9.3.2 Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2022-2027) 9.3.3 Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2027) 9.4 Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Country 9.4.1 Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2016-2021) 9.4.2 Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size (2016-2027) 10.2 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Type 10.2.1 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2027) 10.3 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Application 10.3.1 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2027) 10.4 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Country 10.4.1 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Targeted Drug ALK Inhibitors for NSCLC Introduction 11.1.4 Pfizer Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Targeted Drug ALK Inhibitors for NSCLC Introduction 11.2.4 Novartis Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Chugai Pharmaceutical (Hoffmann-La Roche group) 11.3.1 Chugai Pharmaceutical (Hoffmann-La Roche group) Company Details 11.3.2 Chugai Pharmaceutical (Hoffmann-La Roche group) Business Overview 11.3.3 Chugai Pharmaceutical (Hoffmann-La Roche group) Targeted Drug ALK Inhibitors for NSCLC Introduction 11.3.4 Chugai Pharmaceutical (Hoffmann-La Roche group) Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) 11.3.5 Chugai Pharmaceutical (Hoffmann-La Roche group) Recent Development 11.4 ARIAD Pharmaceuticals (Takeda) 11.4.1 ARIAD Pharmaceuticals (Takeda) Company Details 11.4.2 ARIAD Pharmaceuticals (Takeda) Business Overview 11.4.3 ARIAD Pharmaceuticals (Takeda) Targeted Drug ALK Inhibitors for NSCLC Introduction 11.4.4 ARIAD Pharmaceuticals (Takeda) Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) 11.4.5 ARIAD Pharmaceuticals (Takeda) Recent Development 11.5 Genvio Pharma Limited 11.5.1 Genvio Pharma Limited Company Details 11.5.2 Genvio Pharma Limited Business Overview 11.5.3 Genvio Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Introduction 11.5.4 Genvio Pharma Limited Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) 11.5.5 Genvio Pharma Limited Recent Development 11.6 Beacon Pharma Limited 11.6.1 Beacon Pharma Limited Company Details 11.6.2 Beacon Pharma Limited Business Overview 11.6.3 Beacon Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Introduction 11.6.4 Beacon Pharma Limited Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) 11.6.5 Beacon Pharma Limited Recent Development 11.7 Drug International Limted 11.7.1 Drug International Limted Company Details 11.7.2 Drug International Limted Business Overview 11.7.3 Drug International Limted Targeted Drug ALK Inhibitors for NSCLC Introduction 11.7.4 Drug International Limted Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) 11.7.5 Drug International Limted Recent Development 11.8 Incepta Pharmaceuticals 11.8.1 Incepta Pharmaceuticals Company Details 11.8.2 Incepta Pharmaceuticals Business Overview 11.8.3 Incepta Pharmaceuticals Targeted Drug ALK Inhibitors for NSCLC Introduction 11.8.4 Incepta Pharmaceuticals Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) 11.8.5 Incepta Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Crizotinib Table 3. Key Players of Ceritinib Table 4. Key Players of Alectinib Table 5. Key Players of Brigatinib Table 6. Key Players of Lorlatinib Table 7. Key Players of Other Table 8. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Targeted Drug ALK Inhibitors for NSCLC Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Targeted Drug ALK Inhibitors for NSCLC Market Size by Regions (2016-2021) & (US$ Million) Table 11. Global Targeted Drug ALK Inhibitors for NSCLC Market Share by Regions (2016-2021) Table 12. Global Targeted Drug ALK Inhibitors for NSCLC Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 13. Global Targeted Drug ALK Inhibitors for NSCLC Market Share by Regions (2022-2027) Table 14. Targeted Drug ALK Inhibitors for NSCLC Market Trends Table 15. Targeted Drug ALK Inhibitors for NSCLC Market Drivers Table 16. Targeted Drug ALK Inhibitors for NSCLC Market Challenges Table 17. Targeted Drug ALK Inhibitors for NSCLC Market Restraints Table 18. Global Targeted Drug ALK Inhibitors for NSCLC Revenue by Players (2016-2021) & (US$ Million) Table 19. Global Targeted Drug ALK Inhibitors for NSCLC Market Share by Players (2016-2021) Table 20. Global Top Targeted Drug ALK Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug ALK Inhibitors for NSCLC as of 2020) Table 21. Ranking of Global Top Targeted Drug ALK Inhibitors for NSCLC Companies by Revenue (US$ Million) in 2020 Table 22. Global 5 Largest Players Market Share by Targeted Drug ALK Inhibitors for NSCLC Revenue (CR5 and HHI) & (2016-2021) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Targeted Drug ALK Inhibitors for NSCLC Product Solution and Service Table 25. Date of Enter into Targeted Drug ALK Inhibitors for NSCLC Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2021) (US$ Million) Table 28. Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Type (2016-2021) Table 29. Global Targeted Drug ALK Inhibitors for NSCLC Forecasted Market Size by Type (2022-2027) (US$ Million) Table 30. Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Type (2022-2027) & (US$ Million) Table 31. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Share by Application (2016-2021) & (US$ Million) Table 32. Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Application (2016-2021) Table 33. Global Targeted Drug ALK Inhibitors for NSCLC Forecasted Market Size by Application (2022-2027) (US$ Million) Table 34. Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Application (2022-2027) & (US$ Million) Table 35. North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2021) (US$ Million) Table 36. North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2022-2027) & (US$ Million) Table 37. North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2021) (US$ Million) Table 38. North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2022-2027) & (US$ Million) Table 39. North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 40. North America Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 41. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2021) (US$ Million) Table 42. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2022-2027) & (US$ Million) Table 43. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2021) (US$ Million) Table 44. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2022-2027) & (US$ Million) Table 45. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 46. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 47. Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2021) (US$ Million) Table 48. Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2022-2027) & (US$ Million) Table 49. Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2021) (US$ Million) Table 50. Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2022-2027) & (US$ Million) Table 51. Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Region (2016-2021) & (US$ Million) Table 52. Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size by Region (2022-2027) & (US$ Million) Table 53. Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2021) (US$ Million) Table 54. Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2022-2027) & (US$ Million) Table 55. Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2021) (US$ Million) Table 56. Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2022-2027) & (US$ Million) Table 57. Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 58. Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 59. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2016-2021) (US$ Million) Table 60. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2022-2027) & (US$ Million) Table 61. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2016-2021) (US$ Million) Table 62. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2022-2027) & (US$ Million) Table 63. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 64. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 65. Pfizer Company Details Table 66. Pfizer Business Overview Table 67. Pfizer Targeted Drug ALK Inhibitors for NSCLC Product Table 68. Pfizer Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) & (US$ Million) Table 69. Pfizer Recent Development Table 70. Novartis Company Details Table 71. Novartis Business Overview Table 72. Novartis Targeted Drug ALK Inhibitors for NSCLC Product Table 73. Novartis Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) & (US$ Million) Table 74. Novartis Recent Development Table 75. Chugai Pharmaceutical (Hoffmann-La Roche group) Company Details Table 76. Chugai Pharmaceutical (Hoffmann-La Roche group) Business Overview Table 77. Chugai Pharmaceutical (Hoffmann-La Roche group) Targeted Drug ALK Inhibitors for NSCLC Product Table 78. Chugai Pharmaceutical (Hoffmann-La Roche group) Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) & (US$ Million) Table 79. Chugai Pharmaceutical (Hoffmann-La Roche group) Recent Development Table 80. ARIAD Pharmaceuticals (Takeda) Company Details Table 81. ARIAD Pharmaceuticals (Takeda) Business Overview Table 82. ARIAD Pharmaceuticals (Takeda) Targeted Drug ALK Inhibitors for NSCLC Product Table 83. ARIAD Pharmaceuticals (Takeda) Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) & (US$ Million) Table 84. ARIAD Pharmaceuticals (Takeda) Recent Development Table 85. Genvio Pharma Limited Company Details Table 86. Genvio Pharma Limited Business Overview Table 87. Genvio Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Product Table 88. Genvio Pharma Limited Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) & (US$ Million) Table 89. Genvio Pharma Limited Recent Development Table 90. Beacon Pharma Limited Company Details Table 91. Beacon Pharma Limited Business Overview Table 92. Beacon Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Product Table 93. Beacon Pharma Limited Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) & (US$ Million) Table 94. Beacon Pharma Limited Recent Development Table 95. Drug International Limted Company Details Table 96. Drug International Limted Business Overview Table 97. Drug International Limted Targeted Drug ALK Inhibitors for NSCLC Product Table 98. Drug International Limted Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) & (US$ Million) Table 99. Drug International Limted Recent Development Table 100. Incepta Pharmaceuticals Company Details Table 101. Incepta Pharmaceuticals Business Overview Table 102. Incepta Pharmaceuticals Revenue in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) & (US$ Million) Table 103. Incepta Pharmaceuticals Recent Development Table 104. Research Programs/Design for This Report Table 105. Key Data Information from Secondary Sources Table 106. Key Data Information from Primary Sources List of Figures Figure 1. Global Targeted Drug ALK Inhibitors for NSCLC Market Share by Type: 2020 VS 2027 Figure 2. Crizotinib Features Figure 3. Ceritinib Features Figure 4. Alectinib Features Figure 5. Brigatinib Features Figure 6. Lorlatinib Features Figure 7. Other Features Figure 8. Global Targeted Drug ALK Inhibitors for NSCLC Market Share by Application: 2020 VS 2027 Figure 9. Squamous Cell Carcinoma of NSCLC Case Studies Figure 10. Adenocarcinoma of NSCLC Case Studies Figure 11. Large Cell Carcinoma of NSCLC Case Studies Figure 12. Targeted Drug ALK Inhibitors for NSCLC Report Years Considered Figure 13. Global Targeted Drug ALK Inhibitors for NSCLC Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Targeted Drug ALK Inhibitors for NSCLC Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Targeted Drug ALK Inhibitors for NSCLC Market Share by Regions: 2020 VS 2027 Figure 16. Global Targeted Drug ALK Inhibitors for NSCLC Market Share by Regions (2022-2027) Figure 17. Global Targeted Drug ALK Inhibitors for NSCLC Market Share by Players in 2020 Figure 18. Global Top Targeted Drug ALK Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug ALK Inhibitors for NSCLC as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Targeted Drug ALK Inhibitors for NSCLC Revenue in 2020 Figure 20. Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Type (2016-2021) Figure 21. Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Type (2022-2027) Figure 22. North America Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Targeted Drug ALK Inhibitors for NSCLC Market Share by Type (2016-2027) Figure 24. North America Targeted Drug ALK Inhibitors for NSCLC Market Share by Application (2016-2027) Figure 25. North America Targeted Drug ALK Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 26. United States Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Targeted Drug ALK Inhibitors for NSCLC Market Share by Type (2016-2027) Figure 30. Europe Targeted Drug ALK Inhibitors for NSCLC Market Share by Application (2016-2027) Figure 31. Europe Targeted Drug ALK Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 32. Germany Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Share by Type (2016-2027) Figure 40. Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Share by Application (2016-2027) Figure 41. Asia-Pacific Targeted Drug ALK Inhibitors for NSCLC Market Share by Region (2016-2027) Figure 42. China Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Targeted Drug ALK Inhibitors for NSCLC Market Share by Type (2016-2027) Figure 50. Latin America Targeted Drug ALK Inhibitors for NSCLC Market Share by Application (2016-2027) Figure 51. Latin America Targeted Drug ALK Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 52. Mexico Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Share by Type (2016-2027) Figure 56. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Share by Application (2016-2027) Figure 57. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 58. Turkey Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Targeted Drug ALK Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Pfizer Revenue Growth Rate in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) Figure 62. Novartis Revenue Growth Rate in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) Figure 63. Chugai Pharmaceutical (Hoffmann-La Roche group) Revenue Growth Rate in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) Figure 64. ARIAD Pharmaceuticals (Takeda) Revenue Growth Rate in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) Figure 65. Genvio Pharma Limited Revenue Growth Rate in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) Figure 66. Beacon Pharma Limited Revenue Growth Rate in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) Figure 67. Drug International Limted Revenue Growth Rate in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) Figure 68. Incepta Pharmaceuticals Revenue Growth Rate in Targeted Drug ALK Inhibitors for NSCLC Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Pfizer Novartis Chugai Pharmaceutical (Hoffmann-La Roche group) ARIAD Pharmaceuticals (Takeda) Genvio Pharma Limited Beacon Pharma Limited Drug International Limted Incepta Pharmaceuticals